Also from this source

You just read:

Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C

News provided by

Talecris Biotherapeutics, Inc.

Dec 09, 2010, 01:41 EST